Birks E - Search Results

1

The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.

Bitar A, Vijayakrishnan R, Lenneman A, Birks E, Massey T, Slaughter M, Abramov D. Bitar A, et al. Among authors: birks e. Artif Organs. 2017 Dec;41(12):1092-1098. doi: 10.1111/aor.12910. Epub 2017 Jun 16. Artif Organs. 2017. PMID: 28621461

2

Effect of Blood Group on Heart Transplant Waitlist Mortality in the Ventricular Assist Device Era.

Vaidya GN, Trivedi J, Vijayakrishnan R, Fraser GE, Slaughter MS, Birks E, Abramov D. Vaidya GN, et al. Among authors: birks e. ASAIO J. 2020 Jul;66(7):774-779. doi: 10.1097/MAT.0000000000001080. ASAIO J. 2020. PMID: 31577625

3

Destination therapy with left ventricular assist devices: patient selection and outcomes.

Slaughter MS, Meyer AL, Birks EJ. Slaughter MS, et al. Curr Opin Cardiol. 2011 May;26(3):232-6. doi: 10.1097/HCO.0b013e328345aff4. Curr Opin Cardiol. 2011. PMID: 21430527 Review.

4

The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.

Donneyong M, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter MS. Donneyong M, et al. Among authors: birks ej. ASAIO J. 2014 May-Jun;60(3):294-9. doi: 10.1097/MAT.0000000000000065. ASAIO J. 2014. PMID: 24614355

5

Donor Oversizing Results in Improved Survival in Patients with Left Ventricular Assist Device.

Schumer EM, Black MC, Rogers MP, Trivedi JR, Birks EJ, Lenneman AJ, Cheng A, Slaughter MS. Schumer EM, et al. ASAIO J. 2016 Sep-Oct;62(5):571-7. doi: 10.1097/MAT.0000000000000399. ASAIO J. 2016. PMID: 27258226

6

Differences in Status 1A Heart Transplantation Survival in the Continuous Flow Left Ventricular Assist Device Era.

Trivedi JR, Rajagopal K, Schumer EM, Birks EJ, Lenneman A, Cheng A, Slaughter MS. Trivedi JR, et al. Ann Thorac Surg. 2016 Nov;102(5):1512-1516. doi: 10.1016/j.athoracsur.2016.04.027. Epub 2016 Jun 18. Ann Thorac Surg. 2016. PMID: 27329191

7

Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.

Gallo M, Trivedi JR, Mondal NK, Birks EJ, Slaughter MS. Gallo M, et al. ASAIO J. 2019 Sep/Oct;65(7):683-689. doi: 10.1097/MAT.0000000000000935. ASAIO J. 2019. PMID: 30585872

8

The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation.

Samsky MD, Milano CA, Pamboukian S, Slaughter MS, Birks E, Boyce S, Najjar SS, Itoh A, Reid B, Mokadam N, Aaronson KD, Pagani FD, Rogers JG. Samsky MD, et al. Among authors: birks e. ASAIO J. 2021 Oct 1;67(10):1159-1162. doi: 10.1097/MAT.0000000000001378. ASAIO J. 2021. PMID: 33927085 Free PMC article.

9

Heart Transplant Survival Based on Recipient and Donor Risk Scoring: A UNOS Database Analysis.

Trivedi JR, Cheng A, Ising M, Lenneman A, Birks E, Slaughter MS. Trivedi JR, et al. Among authors: birks e. ASAIO J. 2016 May-Jun;62(3):297-301. doi: 10.1097/MAT.0000000000000337. ASAIO J. 2016. PMID: 26771395

10

Heart transplant vs left ventricular assist device in heart transplant-eligible patients.

Williams ML, Trivedi JR, McCants KC, Prabhu SD, Birks EJ, Oliver L, Slaughter MS. Williams ML, et al. Ann Thorac Surg. 2011 May;91(5):1330-3; discussion 1333-4. doi: 10.1016/j.athoracsur.2011.01.062. Epub 2011 Mar 24. Ann Thorac Surg. 2011. PMID: 21439545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters